This broad based tightly integrated research proposal is aimed at understanding the molecular, cellular and physiological actions of parathyroid hormone (PTH) on bone and kidney and mineral ion homeostasis. A long range goal is to understand the cellular basis of PTH actions which underlie its therapeutic value in osteoporosis. Project I. PTH and PTHrP Interaction with PTH Receptors. Study of the molecular structure of the active biomolecular complex of PTH and its classic receptor (PTHR1) will be pursued further by highly effective, powerful iterative testing approaches using multiple methods of molecular biology and peptide chemistry with structurally minimized ligands and multiple receptor mutants. Project II. Regulation of the PTH/PTHrP Receptor. The biochemical and physiological consequences of altering the normally occurring modulation of surface expression of PTHR1 on target cells will be analyzed in vitro and in vivo with receptor constructs mutagenized to prevent phosphorylation and impair desensitization and internalization of the receptor. Project III. Second Messengers in PTH Action. Evidence that induced selectivity among the diverse signalling pathways of PTHR1 stimulated by PTH lead to distinctive biological responses in bone will be explored by administration of signal-selective PTH ligands in vivo. Cellular mechanisms responsible for altered target cell response will be addressed in vitro with bone-cell lines containing signal selective variants of the PTHR1. Project IV. Role of PLC in PTH Signalling: Mutant Receptors in Vivo. Evidence that abrogation of PLC- dependent PTHR1 signalling leads to abnormalities in bone development, & post-natal bone structural integrity and inducible abnormalities in mineral ion homeostasis (especially through renal mechanisms) will be explored by extensive studies in vivo with a genetically modified mouse strain that lacks signaling through the PLC pathway and mechanism-based studies with cells derived from the mutant mice in vitro. Project V. NHERF- Mediated PTH Signalling in Mineral Ion Homeostasis. NHERF proteins function as part of intracellular scaffold protein complexes that modulate cellular signaling. NHERFs have recently been shown to act as """"""""molecular switches"""""""" that increase activation by PTH of PLC-dependent pathways while suppressing adenyl cyclase pathways. The skeletal role of the NHERF proteins will be studied in vivo (using NHERF-1 knockout animals recently reported to have osteopenia) and in vitro with renal and bone cell lines, the latter derived from knockout animals and/or transfected with NHERF proteins. A versatile peptide core for supply of vital reagents and a newly established Skeletal Phenotyping Core with novel tools for analyses of induced skeletal responses provide critical support for the five projects.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Program Projects (P01)
Project #
5P01DK011794-40
Application #
7325714
Study Section
Special Emphasis Panel (ZDK1-GRB-3 (M2))
Program Officer
Malozowski, Saul N
Project Start
1997-08-01
Project End
2008-11-30
Budget Start
2007-12-01
Budget End
2008-11-30
Support Year
40
Fiscal Year
2008
Total Cost
$1,880,831
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Christov, Marta; Clark, Abbe R; Corbin, Braden et al. (2018) Inducible podocyte-specific deletion of CTCF drives progressive kidney disease and bone abnormalities. JCI Insight 3:
Dedic, Christopher; Hung, Tin Shing; Shipley, Alan M et al. (2018) Calcium fluxes at the bone/plasma interface: Acute effects of parathyroid hormone (PTH) and targeted deletion of PTH/PTH-related peptide (PTHrP) receptor in the osteocytes. Bone 116:135-143
Mizuhashi, Koji; Ono, Wanida; Matsushita, Yuki et al. (2018) Resting zone of the growth plate houses a unique class of skeletal stem cells. Nature 563:254-258
Hanna, Patrick; Grybek, Virginie; Perez de Nanclares, Guiomar et al. (2018) Genetic and Epigenetic Defects at the GNAS Locus Lead to Distinct Patterns of Skeletal Growth but Similar Early-Onset Obesity. J Bone Miner Res 33:1480-1488
Wein, Marc N; Foretz, Marc; Fisher, David E et al. (2018) Salt-Inducible Kinases: Physiology, Regulation by cAMP, and Therapeutic Potential. Trends Endocrinol Metab 29:723-735
Bastepe, Murat (2018) GNAS mutations and heterotopic ossification. Bone 109:80-85
Grigelioniene, Giedre; Nevalainen, Pasi I; Reyes, Monica et al. (2017) A Large Inversion Involving GNAS Exon A/B and All Exons Encoding Gs? Is Associated With Autosomal Dominant Pseudohypoparathyroidism Type Ib (PHP1B). J Bone Miner Res 32:776-783
Balani, Deepak H; Ono, Noriaki; Kronenberg, Henry M (2017) Parathyroid hormone regulates fates of murine osteoblast precursors in vivo. J Clin Invest 127:3327-3338
Cheloha, Ross W; Chen, Bingming; Kumar, Niyanta N et al. (2017) Development of Potent, Protease-Resistant Agonists of the Parathyroid Hormone Receptor with Broad ? Residue Distribution. J Med Chem 60:8816-8833
Mitchell, Deborah M; J├╝ppner, Harald; Burnett-Bowie, Sherri-Ann M (2017) FGF23 Is Not Associated With Age-Related Changes in Phosphate, but Enhances Renal Calcium Reabsorption in Girls. J Clin Endocrinol Metab 102:1151-1160

Showing the most recent 10 out of 215 publications